{"disease":{"id":"basal-cell-carcinoma","name":"Basal Cell Carcinoma","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":8},"drugs":{"marketed":[{"drug_id":"cemiplimab","indication_name":"Metastatic basal cell carcinoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Libtayo","generic_name":"CEMIPLIMAB","company_name":"Regeneron Pharmaceuticals ","drug_phase":"marketed","molecular_target":"PD-1","drug_class":"","quality_score":64,"revenue":"1452","mechanism":"Cemiplimab-rwlc binds to PD-1 and blocks its interaction with PD-L1 and PD-L2, enhancing the immune response against tumors."},{"drug_id":"5-fu","indication_name":"Superficial basal cell carcinoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Carac","generic_name":"5-fu","company_name":"Spectrum Pharms","drug_phase":"marketed","molecular_target":"Aromatase","drug_class":"Nucleoside Metabolic Inhibitor","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"erismodegib","indication_name":"Basal cell carcinoma of skin","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Erismodegib","company_name":"Washington University School of Medicine","drug_phase":"discontinued","molecular_target":"Smoothened homolog, Sonic hedgehog protein","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"tumor-tissue","indication_name":"Basal Cell Carcinoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tumor Tissue","generic_name":"tumor-tissue","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"fluorouracil","indication_name":"Superficial basal cell carcinoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Carac","generic_name":"fluorouracil","company_name":"Extrovis","drug_phase":"marketed","molecular_target":"Aromatase","drug_class":"Nucleoside Metabolic Inhibitor [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"vismodegib","indication_name":"Basal cell carcinoma of skin","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Erivedge","generic_name":"vismodegib","company_name":"Roche","drug_phase":"marketed","molecular_target":"Smoothened","drug_class":"Hedgehog Pathway Inhibitor [EPC]","quality_score":70,"revenue":null,"mechanism":"Vismodegib inhibits the Hedgehog pathway by binding to and blocking Smoothened, a key protein in the pathway."},{"drug_id":"chembl-chembl185","indication_name":"Superficial Basal Cell Carcinomas","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"FLUOROURACIL","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Nucleoside Metabolic Inhibitor [EPC]","quality_score":13,"revenue":null,"mechanism":null},{"drug_id":"imiquimod","indication_name":"Superficial basal cell carcinoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aldara","generic_name":"IMIQUIMOD","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"7,8-dihydro-8-oxoguanine triphosphatase","drug_class":"imiquimod","quality_score":75,"revenue":null,"mechanism":"Aldara works by activating the immune system to recognize and attack abnormal cells."}],"pipeline":[],"offLabel":[],"totalMarketed":8,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04969419","title":"Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo","phase":"","overall_status":"COMPLETED","enrollment_count":75771,"lead_sponsor_name":"Momentum Data","has_results":true},{"nct_id":"NCT03210935","title":"French National Database of Rare Dermatological Cancers","phase":"","overall_status":"UNKNOWN","enrollment_count":9000,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT02310503","title":"Spanish Registry of Mohs Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":6000,"lead_sponsor_name":"Fundación Academia Española de Dermatología","has_results":false},{"nct_id":"NCT03621462","title":"Elucid Labs AIDA™ - Labelled Image Acquisition Protocol","phase":"NA","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Elucid Labs Inc.","has_results":false},{"nct_id":"NCT06705608","title":"Examining the Risk of Skin Cancer in Multiple Sclerosis Patients Using Fingolimod: a Population-Based Study","phase":"","overall_status":"COMPLETED","enrollment_count":4000,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT06661577","title":"An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"University of Auckland, New Zealand","has_results":false},{"nct_id":"NCT07347392","title":"The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark.","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2900,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT02825511","title":"Assessment of the Clinic-pathological Correlation of Basal Cell Carcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":2738,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT04814953","title":"HRQoL Keratinocyte Carcinomas","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2400,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT03509467","title":"Using MC1R Genotype to Impact Melanoma Risk Behavior","phase":"NA","overall_status":"COMPLETED","enrollment_count":2054,"lead_sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","has_results":true},{"nct_id":"NCT05212246","title":"Basal Cell Carcinoma Chemoprevention Trial","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":1630,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT03050268","title":"Familial Investigations of Childhood Cancer Predisposition","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT01367665","title":"STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1232,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT05126173","title":"DERM US and EU Validation Study","phase":"","overall_status":"COMPLETED","enrollment_count":1111,"lead_sponsor_name":"Skin Analytics Limited","has_results":false},{"nct_id":"NCT06600165","title":"Intraoperative Confocal Laser Scanning Microscopy With Use of AI for Optimized Surgical Excision of Basal Cell Carcinoma","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"LMU Klinikum","has_results":false},{"nct_id":"NCT06536257","title":"Personalised Immunotherapy Platform","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Melanoma Institute Australia","has_results":false},{"nct_id":"NCT05041777","title":"Optical-Coherence Tomography for the Non-invasive Diagnosis and Subtyping of Basal Cell Carcinoma","phase":"","overall_status":"UNKNOWN","enrollment_count":963,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT00847912","title":"CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":954,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT02834013","title":"Nivolumab and Ipilimumab in Treating Patients With Rare Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":818,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04795297","title":"Observational Study of Correlation Between Recurrent Basal Cell Carcinoma and Localisation","phase":"","overall_status":"COMPLETED","enrollment_count":804,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT06448936","title":"Quality of Life in Patients With Difficult-to-Treat Basal Cell Carcinoma: An Evaluation of Impact and Surgical Outcomes.","phase":"","overall_status":"RECRUITING","enrollment_count":750,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT05078047","title":"Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":646,"lead_sponsor_name":"UNICANCER","has_results":false},{"nct_id":"NCT06598137","title":"Study to Examine Lesions of the Skin Using Confocal Laser Microscopy","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":645,"lead_sponsor_name":"LMU Klinikum","has_results":false},{"nct_id":"NCT01604252","title":"An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)","phase":"","overall_status":"TERMINATED","enrollment_count":503,"lead_sponsor_name":"Genentech, Inc.","has_results":false},{"nct_id":"NCT03092830","title":"Molecular Characterization of Cutaneous Tumors","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Rabin Medical Center","has_results":false},{"nct_id":"NCT05853315","title":"BCC Excision Revisited","phase":"","overall_status":"COMPLETED","enrollment_count":451,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT06273722","title":"D-OCT for Detection and Subtyping of BCC: a Diagnostic Cohort Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":424,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT07361666","title":"Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Head and Neck Skin Cancer, and the Relationship Between Preoperative Assessment Methods, Inadequate Excision Margins, and Tumor Recurrence","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji","has_results":false},{"nct_id":"NCT06342297","title":"Dermatoscopy Guided Resection for Skin Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Region Örebro County","has_results":false},{"nct_id":"NCT06683846","title":"Ivonescimab in the Treatment of Multiple Advanced Tumors","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT03952585","title":"De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":384,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT03331874","title":"RCM to Diagnose BCC - Reflectance Confocal Microscopy to Diagnose Basal Cell Carcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":352,"lead_sponsor_name":"Julie Dawson","has_results":false},{"nct_id":"NCT03233711","title":"Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":344,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03509415","title":"Reflectance Confocal Microscopy to Diagnose BCC","phase":"","overall_status":"COMPLETED","enrollment_count":324,"lead_sponsor_name":"Skin Care Network Ltd.","has_results":false},{"nct_id":"NCT04066504","title":"Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":323,"lead_sponsor_name":"Sun Pharmaceutical Industries Limited","has_results":false},{"nct_id":"NCT00046189","title":"Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum","phase":"","overall_status":"COMPLETED","enrollment_count":301,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04842279","title":"FACE-Q in Facial Reconstructive Surgery: A Prospective Database","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT06227416","title":"Skin Tumor Biomarkers by Mass Spectrometry Imaging","phase":"NA","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Bispebjerg Hospital","has_results":false},{"nct_id":"NCT07501780","title":"Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":297,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT07384078","title":"High Intensity Focused Ultrasound vs. Cryotherapy in the Treatment of Basal Cell Carcinomas and Bowen's Disease in Adults","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":294,"lead_sponsor_name":"Jussi Salonen","has_results":false},{"nct_id":"NCT07482956","title":"BCC-One-Stop-Study","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":290,"lead_sponsor_name":"University Hospital Augsburg","has_results":false},{"nct_id":"NCT03836105","title":"CemiplimAb Survivorship Epidemiology","phase":"","overall_status":"COMPLETED","enrollment_count":287,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT02144077","title":"Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":281,"lead_sponsor_name":"Biofrontera Bioscience GmbH","has_results":true},{"nct_id":"NCT04166318","title":"Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":252,"lead_sponsor_name":"ECOG-ACRIN Cancer Research Group","has_results":false},{"nct_id":"NCT06309836","title":"Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse","has_results":false},{"nct_id":"NCT01327053","title":"A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT01815840","title":"A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":229,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT05628714","title":"A Patient Decision Aid for Patients With Superficial Basal Cell Carcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":222,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT05969860","title":"At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03237013","title":"Strategies to Promote Skin Health","phase":"NA","overall_status":"COMPLETED","enrollment_count":219,"lead_sponsor_name":"San Diego State University","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}